NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis.

W Denning, D; Y Lee, J; S Hostetler, J; Pappas, P; A Kauffman, C; H Dewsnup, D; N Galgiani, J; R Graybill, J; M Sugar, A; Catanzaro, A

doi:10.1016/0002-9343(94)90023-x

Public

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis.

Shared by NobleBlocks on Aug 1, 1994 • 12:00 AM UTC

Authors:

D W Denning

J Y Lee

J S Hostetler

Abstract

BACKGROUND: Invasive aspergillosis is the most common invasive mould infection and a major cause of mortality in immunocompromised patients. Response to amphotericin B, the only antifungal agent licensed in the United States for the treatment of aspergillosis, is suboptimal. METHODS: A multicenter o...

Discussions